NDC 69097-639 – Nintedanib
Nintedanib Esylate 150 mg/1 · Capsule · Oral
Product NDC69097-639
Product details
- Brand name
- Nintedanib
- Generic name
- Nintedanib
- Labeler
- Cipla USA Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA212609
- Marketed since
- April 2, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Nintedanib Esylate 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69097-639-03 | 60 CAPSULE in 1 BOTTLE (69097-639-03) | Apr 2, 2026 |
Other Nintedanib products
- 60505-4818 Nintedanib Esylate 100 mg/1 · Capsule · Apotex Corp.
- 60505-4819 Nintedanib Esylate 150 mg/1 · Capsule · Apotex Corp.
- 73190-097 Nintedanib Esylate 150 mg/1 · Capsule · AvKARE
- 73190-096 Nintedanib Esylate 100 mg/1 · Capsule · AvKARE
- 69097-641 Nintedanib Esylate 100 mg/1 · Capsule · Cipla USA Inc.
- 43598-147 Nintedanib Esylate 150 mg/1 · Capsule · Dr. Reddy's Laboratories Inc.
- 43598-148 Nintedanib Esylate 100 mg/1 · Capsule · Dr. Reddy's Laboratories Inc.
- 42799-972 Nintedanib Esylate 100 mg/1 · Capsule · Edenbridge Pharmaceuticals LLC.
- 42799-973 Nintedanib Esylate 150 mg/1 · Capsule · Edenbridge Pharmaceuticals LLC.
- 42806-568 Nintedanib Esylate 150 mg/1 · Capsule · EPIC PHARMA LLC
- 42806-569 Nintedanib Esylate 100 mg/1 · Capsule · EPIC PHARMA LLC
- 68462-802 Nintedanib Esylate 100 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA